Display options
Share it on

Clin Kidney J. 2012 Aug;5(4):350-1. doi: 10.1093/ckj/sfs076.

Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient.

Clinical kidney journal

Gabriele Eden, Olaf Burkhardt, Christian Clajus, Jan T Kielstein

Affiliations

  1. Department of Nephrology and Hypertension , Medical School Hannover , Hannover , Germany.
  2. Department of Pulmonary Medicine , Medical School Hannover , Hannover , Germany.

PMID: 25874096 PMCID: PMC4393481 DOI: 10.1093/ckj/sfs076

Abstract

There is an increasing prevalence of urinary tract infection (UTI) caused by multiresistant gram-negative enteric bacilli such as extended-spectrum beta-lactamase as well as Gram-positive enterococci whose vancomycin-resistance can be as high as 25%. We report on a 68-year-old Caucasian female with a UTI caused by a vancomycin-resistant Enterococcus faecium, only tested to be susceptible to gentamycin, linezolid and daptomycin. Within a day after administration of the bactericidal daptomycin clinical and laboratory signs of infection regressed and graft function recovered. Our case suggests that daptomycin might be an effective alternative for UTI caused by vancomycin-resistant enterococci.

Keywords: renal transplant recipient; urinary tract infection; vancomycin-resistant entorococci

References

  1. Clin J Am Soc Nephrol. 2011 May;6(5):1081-8 - PubMed
  2. Chemotherapy. 2005 May;51(2-3):64-9 - PubMed
  3. Curr Infect Dis Rep. 2010 Nov;12(6):455-64 - PubMed
  4. Nat Clin Pract Nephrol. 2008 May;4(5):252-64 - PubMed
  5. Diagn Microbiol Infect Dis. 2007 Jun;58(2):163-70 - PubMed
  6. Nephrol Dial Transplant. 2010 Apr;25(4):1279-84 - PubMed
  7. Nephrol Dial Transplant. 2010 May;25(5):1537-41 - PubMed
  8. Pharmacotherapy. 2011 Jul;31(7):665-72 - PubMed
  9. Pharmacotherapy. 2010 Nov;30(11):1136-49 - PubMed
  10. Crit Care Med. 2011 Jan;39(1):19-25 - PubMed

Publication Types